East Hanover, NJNCT07029542Now EnrollingIRB Ready

C3 Glomerulopathy Clinical Trial in East Hanover, NJ

Access cutting-edge c3 glomerulopathy treatment through this clinical trial at a research site in East Hanover. Study-provided care at no cost to qualified participants.

Sponsored by Novartis Pharmaceuticals

Quick Self-Assessment

See if you qualify for this East Hanover location

Preparing your pre-screening questions…

Expert Care in East Hanover

Access c3 glomerulopathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related c3 glomerulopathy treatment provided free

Apply for This East Hanover Location

Check if you qualify for this c3 glomerulopathy clinical trial in East Hanover, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to East Hanover

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit East Hanover site if eligible
  4. 4Begin participation

About This C3 Glomerulopathy Study in East Hanover

The study aims to longitudinally capture the full spectrum of symptoms, treatment utilization, and overall Health-related Quality of Life (HRQoL) experienced by C3 glomerulopathy (C3G) patients and their caregivers. By primarily utilizing home reported outcomes (HRO) data on symptom burden and treatment usage, supplemented with patient-reported outcome (PRO) measures (collected at baseline and monthly), the study seeks to establish a new real-world data (RWD) source to understand symptom variability and HRQoL as reported by C3G patients and caregivers, including those taking iptacopan

Sponsor: Novartis Pharmaceuticals

Who Can Participate

Inclusion Criteria

Eligible participants will meet the following basic criteria:
Clinical diagnosis of C3G, regardless of symptom, treatment, or transplant history
Adult aged 18 or older; adult caregiver to an adult patient aged 18 or older; or adult caregiver to a pediatric patient under 18 years of age
Able to provide informed consent
Has access to technology (i.e. mobile phone, tablet) that facilitates their participation in the app-based study
US-based with a proficient understanding of and ability to read the English language The study team will aim to enroll and collect data on participants who are taking any form of treatment. Participants may be asked to recall the start date of taking their current therapy. Diagnosis of C3G will be confirmed through self-reported screening procedures, patient-supplied documentation, and/or successful linkage of the patient's data with their record in a Novartis data platform. Confirmation of diagnosis for each participant will be reviewed by the Folia Health study team as part of standard validation procedures.

Exclusion Criteria

Study participants who do not fit all inclusion criteria listed above are unable to participate in this study. Outside of the stated inclusion criteria, there is currently no other exclusion criteria in order to meet the exploratory nature of the primary endpoint. This includes treatment regimen; there is no exclusion criteria on the basis of treatment prescription or use.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in East Hanover?

Yes, this clinical trial (NCT07029542) has an active research site in East Hanover, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

C3 Glomerulopathy Treatment Options in East Hanover, NJ

If you're searching for c3 glomerulopathy treatment options in East Hanover, NJ, this clinical trial (NCT07029542) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our East Hanover research site is actively enrolling participants for this clinical trial. You'll receive care from experienced c3 glomerulopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all c3 glomerulopathy clinical trials near you to find additional studies recruiting in your area.

More Myalgic Encephalomyelitis Trials in East Hanover, NJ

See all myalgic encephalomyelitis clinical trials recruiting in East Hanover — not just this study.

Browse Myalgic Encephalomyelitis Trials in East Hanover →

Browse More Trials by Condition

Myalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in East Hanover?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · East Hanover, NJ